MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, K.
Right arrow Articles by Ascoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, K.
Right arrow Articles by Ascoli, M.

Vol. 56, Issue 4, 728-736, October 1999

A Dileucine-Based Motif in the C-Terminal Tail of the Lutropin/Choriogonadotropin Receptor Inhibits Endocytosis of the Agonist-Receptor Complex

Kazuto Nakamura and Mario Ascoli

Department of Pharmacology, The University of Iowa, Iowa City, Iowa

The rat lutropin/choriogonadotropin receptor (rLHR) is a member of the rhodopsin-like subfamily of G protein-coupled receptors that has two adjacent dileucine motifs in the C-terminal cytoplasmic tail. Here we show that simultaneous (L613,614,615,616A) or individual (L613,L614A or L615,616A) mutation of the two adjacent dileucine motifs to alanines results in mutants with enhanced rates of agonist-induced internalization. The L613,L614A mutation was much more effective in enhancing internalization than the L615,L616A mutation. Moreover, the L613A mutation was more effective than the L614A mutation. Because in the human LHR the residues equivalent to L613 and L614 of the rLHR are a phenylalanine and a leucine (F635 and L636), we also prepared mutants that exchanged these motifs. In the rLHR, an LL-to-FL exchange enhanced endocytosis, and in the human LHR, an FL-to-LL exchange impaired endocytosis. The internalization of rLHR-wt and rLRH-L613,L614A was inhibited by coexpression of the clathrin-binding domain of beta -arrestin. In fact, this manipulation reduced the enhanced rate of internalization of rLHR-L613,614A back to that of rLHR-wt. The L613,614A mutation does not affect the degradation of the internalized agonist or the membrane targeting of the nascent rLHR. The L615,616A mutation also did not affect degradation of the internalized agonist but impaired the membrane targeting of the nascent rLHR. We conclude that the dileucine-based motifs of the rLHR inhibit internalization and suggest that this inhibition may be due to an impairment in the binding of the rLHR to endogenous nonvisual arrestins.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
C. Galet and M. Ascoli
A Constitutively Active Mutant of the Human Lutropin Receptor (hLHR-L457R) Escapes Lysosomal Targeting and Degradation
Mol. Endocrinol., November 1, 2006; 20(11): 2931 - 2945.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kuwasako, Y.-N. Cao, C.-P. Chu, S. Iwatsubo, T. Eto, and K. Kitamura
Functions of the Cytoplasmic Tails of the Human Receptor Activity-modifying Protein Components of Calcitonin Gene-related Peptide and Adrenomedullin Receptors
J. Biol. Chem., March 17, 2006; 281(11): 7205 - 7213.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Yamashita, K. Nakamura, Y. Omori, K. Tsunekawa, M. Murakami, and T. Minegishi
Association of Human Follitropin (FSH) Receptor with Splicing Variant of Human Lutropin/Choriogonadotropin Receptor Negatively Controls the Expression of Human FSH Receptor
Mol. Endocrinol., August 1, 2005; 19(8): 2099 - 2111.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
U. M. Munshi, C. L. Clouser, H. Peegel, and K. M. J. Menon
Evidence that Palmitoylation of Carboxyl Terminus Cysteine Residues of the Human Luteinizing Hormone Receptor Regulates Postendocytic Processing
Mol. Endocrinol., March 1, 2005; 19(3): 749 - 758.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Nakamura, S. Yamashita, Y. Omori, and T. Minegishi
A Splice Variant of the Human Luteinizing Hormone (LH) Receptor Modulates the Expression of Wild-Type Human LH Receptor
Mol. Endocrinol., June 1, 2004; 18(6): 1461 - 1470.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Galet, T. Hirakawa, and M. Ascoli
The Postendocytotic Trafficking of the Human Lutropin Receptor Is Mediated by a Transferable Motif Consisting of the C-Terminal Cysteine and an Upstream Leucine
Mol. Endocrinol., February 1, 2004; 18(2): 434 - 446.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hirakawa, C. Galet, M. Kishi, and M. Ascoli
GIPC Binds to the Human Lutropin Receptor (hLHR) through an Unusual PDZ Domain Binding Motif, and It Regulates the Sorting of the Internalized Human Choriogonadotropin and the Density of Cell Surface hLHR
J. Biol. Chem., December 5, 2003; 278(49): 49348 - 49357.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wang, H. H. Loh, and P.-Y. Law
The Intracellular Trafficking of Opioid Receptors Directed by Carboxyl Tail and a Di-leucine Motif in Neuro2A Cells
J. Biol. Chem., September 19, 2003; 278(38): 36848 - 36858.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. VanLeeuwen, M. E. Steffey, C. Donahue, G. Ho, and R. G. MacKenzie
Cell Surface Expression of the Melanocortin-4 Receptor Is Dependent on a C-terminal Di-isoleucine Sequence at Codons 316/317
J. Biol. Chem., April 25, 2003; 278(18): 15935 - 15940.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Galet, L. Min, R. Narayanan, M. Kishi, N. L. Weigel, and M. Ascoli
Identification of a Transferable Two-Amino-Acid Motif (GT) Present in the C-Terminal Tail of the Human Lutropin Receptor that Redirects Internalized G Protein-Coupled Receptors from a Degradation to a Recycling Pathway
Mol. Endocrinol., March 1, 2003; 17(3): 411 - 422.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Ascoli, F. Fanelli, and D. L. Segaloff
The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective
Endocr. Rev., April 1, 2002; 23(2): 141 - 174.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Kishi, X. Liu, T. Hirakawa, D. Reczek, A. Bretscher, and M. Ascoli
Identification of Two Distinct Structural Motifs That, When Added to the C-Terminal Tail of the Rat LH Receptor, Redirect the Internalized Hormone-Receptor Complex from a Degradation to a Recycling Pathway
Mol. Endocrinol., September 1, 2001; 15(9): 1624 - 1635.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. S. G. Ferguson
Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
Pharmacol. Rev., March 1, 2001; 53(1): 1 - 24.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Min and M. Ascoli
Effect of Activating and Inactivating Mutations on the Phosphorylation and Trafficking of the Human Lutropin/Choriogonadotropin Receptor
Mol. Endocrinol., November 1, 2000; 14(11): 1797 - 1810.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
M. Kishi and M. Ascoli
The C-Terminal Tail of the Rat Lutropin/Choriogonadotropin (CG) Receptor Independently Modulates Human (h)CG-Induced Internalization of the Cell Surface Receptor and the Lysosomal Targeting of the Internalized hCG-Receptor Complex
Mol. Endocrinol., June 1, 2000; 14(6): 926 - 936.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Li, X. Liu, and M. Ascoli
p38JAB1 Binds to the Intracellular Precursor of the Lutropin/Choriogonadotropin Receptor and Promotes Its Degradation
J. Biol. Chem., April 28, 2000; 275(18): 13386 - 13393.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Nakamura, X. Liu, and M. Ascoli
Seven Non-contiguous Intracellular Residues of the Lutropin/Choriogonadotropin Receptor Dictate the Rate of Agonist-induced Internalization and Its Sensitivity to Non-visual Arrestins
J. Biol. Chem., January 7, 2000; 275(1): 241 - 247.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kishi and M. Ascoli
Multiple Distant Amino Acid Residues Present in the Serpentine Region of the Follitropin Receptor Modulate the Rate of Agonist-induced Internalization
J. Biol. Chem., September 29, 2000; 275(40): 31030 - 31037.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Li, X. Liu, L. Min, and M. Ascoli
Mutations of the Second Extracellular Loop of the Human Lutropin Receptor Emphasize the Importance of Receptor Activation and De-emphasize the Importance of Receptor Phosphorylation in Agonist-induced Internalization
J. Biol. Chem., March 9, 2001; 276(11): 7968 - 7973.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kawakami, F. Takeshita, and R. K. Puri
Identification of Distinct Roles for a Dileucine and a Tyrosine Internalization Motif in the Interleukin (IL)-13 Binding Component IL-13 Receptor alpha 2 Chain
J. Biol. Chem., June 29, 2001; 276(27): 25114 - 25120.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Min, C. Galet, and M. Ascoli
The Association of Arrestin-3 with the Human Lutropin/Choriogonadotropin Receptor Depends Mostly on Receptor Activation Rather than on Receptor Phosphorylation
J. Biol. Chem., January 4, 2002; 277(1): 702 - 710.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics